Literature DB >> 21626543

Milestones in magnetic resonance imaging and transcranial sonography of movement disorders.

Daniela Berg1, Jonathan D Steinberger, C Warren Olanow, Thomas P Naidich, Tarek A Yousry.   

Abstract

Twenty-five years ago, when this journal was initiated, imaging of movement disorders was in its infancy. Since that time, magnetic resonance imaging has become a standard technique that is routinely performed in patients with movement disorders in order to exclude secondary causes and in some instances to provide specific information that aids in making the diagnosis of a neurodegenerative condition. Transcranial sonography is a more recent advance and is now widely employed to aid in the diagnosis of Parkinson's disease and possibly in detecting individuals in the premotor phases of the disease. Investigations are currently under way to evaluate the value of this technique in other movement disorders.
Copyright © 2011 Movement Disorder Society.

Entities:  

Mesh:

Year:  2011        PMID: 21626543     DOI: 10.1002/mds.23766

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  12 in total

1.  The Hummingbird sign: a diagnostic clue for Steele-Richardson-Olszweski syndrome.

Authors:  Nikhil Sonthalia; Sayantan Ray
Journal:  BMJ Case Rep       Date:  2012-09-17

Review 2.  Biomarkers for Parkinson's Disease: Recent Advancement.

Authors:  Sharvari Lotankar; Kedar S Prabhavalkar; Lokesh K Bhatt
Journal:  Neurosci Bull       Date:  2017-09-21       Impact factor: 5.203

3.  Transcranial sonography image characteristics in different Parkinson's disease subtypes.

Authors:  Ai Yan Sheng; Ying Chun Zhang; Yu Jing Sheng; Cai Shan Wang; Ying Zhang; Hua Hu; Wei Feng Luo; CHun-Feng LIu
Journal:  Neurol Sci       Date:  2017-07-19       Impact factor: 3.307

4.  Conventional Magnetic Resonance Imaging in the Diagnosis of Parkinsonian Disorders: A Meta-Analysis.

Authors:  Will Lee
Journal:  Mov Disord Clin Pract       Date:  2020-09-14

5.  Atypical Parkinsonian Syndromes and Subtypes of Parkinson's Disease. Will a Single Neuroimaging Modality Ever Be Enough?

Authors:  Nicola Pavese
Journal:  Mov Disord Clin Pract       Date:  2021-01-08

6.  Patterns of gray matter atrophy in atypical parkinsonism syndromes: a VBM meta-analysis.

Authors:  Fang Yu; Daniel S Barron; Bundhit Tantiwongkosi; Peter Fox
Journal:  Brain Behav       Date:  2015-03-11       Impact factor: 2.708

7.  Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.

Authors:  Hiroaki Fujita; Keisuke Suzuki; Ayaka Numao; Yuji Watanabe; Tomoyuki Uchiyama; Tomoyuki Miyamoto; Masayuki Miyamoto; Koichi Hirata
Journal:  PLoS One       Date:  2016-11-03       Impact factor: 3.240

8.  Substantia Nigra Echogenicity Predicts Response to Drug Withdrawal in Suspected Drug-Induced Parkinsonism.

Authors:  Jose L López-Sendón Moreno; Araceli Alonso-Cánovas; Javier Buisán Catevilla; Nuria García Barragán; Iñigo Corral Corral; Alicia de Felipe Mimbrera; María Consuelo Matute Lozano; Jaime Masjuan Vallejo; Juan Carlos Martínez-Castrillo
Journal:  Mov Disord Clin Pract       Date:  2015-12-18

9.  Hummingbird sign in progressive supranuclear palsy disease.

Authors:  Sanjay Pandey
Journal:  J Res Med Sci       Date:  2012-02       Impact factor: 1.852

10.  Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis.

Authors:  Stefan T Schwarz; Maryam Abaei; Vamsi Gontu; Paul S Morgan; Nin Bajaj; Dorothee P Auer
Journal:  Neuroimage Clin       Date:  2013-10-14       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.